These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8418724)

  • 21. Prolonged neuromuscular block associated with mivacurium.
    Fox MH; Hunt PC
    Br J Anaesth; 1995 Feb; 74(2):237-8. PubMed ID: 7696077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prolonged neuromuscular blockade caused by mivacurium in a pediatric patient].
    Fernández-Rosado B; Vázquez-Fidalgo A; Pensado-Castiñeiras A; Figueira-Moure A; Rama-Maceiras P; Pose-Cambeiro P
    Rev Esp Anestesiol Reanim; 1999 Feb; 46(2):92. PubMed ID: 10100446
    [No Abstract]   [Full Text] [Related]  

  • 23. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
    Frampton JE; McTavish D
    Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase.
    Ostergaard D; Jensen FS; Viby-Mogensen J
    Anesthesiology; 1995 May; 82(5):1295-8. PubMed ID: 7741307
    [No Abstract]   [Full Text] [Related]  

  • 25. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
    Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
    Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prolonged neuromuscular block with mivacurium].
    Rodríguez-González MM; Arribas-Carrión C; Torre-Aznar C; González-Miranda F
    Rev Esp Anestesiol Reanim; 1997 Oct; 44(8):328-9. PubMed ID: 9424688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromuscular interactions between mivacurium and esmolol in rabbits.
    Kim KS; Kim KH; Shin WJ; Yoo HK
    Anaesthesia; 1998 Feb; 53(2):140-5. PubMed ID: 9534636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of the monitoring of curarisation during prolonged mivacurium induced neuromuscular block].
    Avargues P; Cros AM; Dardel E; Darriet M; Biteau N
    Ann Fr Anesth Reanim; 1995; 14(6):511-3. PubMed ID: 8745977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterozygous pseudocholinesterase deficiency: a case report and review of the literature.
    Maiorana A; Roach RB
    J Oral Maxillofac Surg; 2003 Jul; 61(7):845-7. PubMed ID: 12856264
    [No Abstract]   [Full Text] [Related]  

  • 30. [Congenital pseudocholinesterase deficiency].
    Gelo R; Jurek-Gelo A; Wardaszko R; Kański A
    Anestezjol Intens Ter; 2011; 43(1):33-5. PubMed ID: 21786528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports.
    Cassel J; Staehr-Rye AK; Nielsen CV; Gätke MR
    Acta Anaesthesiol Scand; 2014 Sep; 58(8):1040-3. PubMed ID: 24947746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Markedly prolonged paralysis after mivacurium in a patient apparently heterozygous for the atypical and usual pseudocholinesterase alleles by conventional biochemical testing.
    Rosenberg MK; Lebenbom-Mansour M
    Anesth Analg; 1997 Feb; 84(2):457-60. PubMed ID: 9024049
    [No Abstract]   [Full Text] [Related]  

  • 33. The neuromuscular effects of mivacurium chloride during propofol anesthesia in children.
    Shorten GD; Crawford MW; St Louis P
    Anesth Analg; 1996 Jun; 82(6):1170-5. PubMed ID: 8638786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase.
    Naguib M; Daoud W; el-Gammal M; Ammar A; Turkistani A; Selim M; Altamimi W; Sohaibani MO
    Anesthesiology; 1995 Oct; 83(4):694-701. PubMed ID: 7574048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuromuscular and cardiovascular effect of mivacurium in anesthesia induction in patients with renal failure].
    Blobner M; Jelen-Esselborn S; Mann R; Kling M; Schneider G; Schneck HJ; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):15-21. PubMed ID: 8868527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block.
    Beaufort TM; Nigrovic V; Proost JH; Houwertjes MC; Wierda JM
    Anesthesiology; 1998 Sep; 89(3):707-14. PubMed ID: 9743409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexpected prolonged neuromuscular block after mivacurium: a case report.
    Hemadri M; Purva M; Traykova V
    Med Princ Pract; 2002; 11(1):50-2. PubMed ID: 12116697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mivacurium sensitivity in a patient heterozygous for the atypical and silent genes for plasma cholinesterase.
    Robertson WS; Shaikh J; Purdie DW
    Ann Clin Biochem; 1995 Jul; 32 ( Pt 4)():431-3. PubMed ID: 7486808
    [No Abstract]   [Full Text] [Related]  

  • 39. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
    Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
    Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mivacurium chloride and myotonic dystrophy.
    Watt NA; Scott RP
    Br J Anaesth; 1995 Oct; 75(4):498-9. PubMed ID: 7488498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.